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1725-51 Improved Outcome in Patients with Prior
Percutaneous Transluminal Coronary Angioplasty
and an Evolving Myocardial Infarction
Marino Labinaz, Michael H. Sketch, Jr., Amanda L. Stebbins, Alec Vahanian, Eric
J. Topol. Robert M. Califf, GUSTO Investigators. Duke University Medical Center,
Durham, N. C.
Despite the increasing prevalence of PTCA, the outcome of patients with
prior PTCA who present with an MI and are treated with thrombolytic ther-
apy is unknown. We compared the outcome of the 1647 patients in GUSTO
who had undergone a prior PTCA with the 39,150 patients who had not un-
dergone a prior PTCA. Patients with a prior PTCA had a higher incidence of
previous MI167 vs 14%) and CABG (19 vs 4%), lower ejection fraction (50 vs
52%), less anterior MI134 vs 39%), and lower systolic bp (127.6 vs 129.1). In
addition, their mean age was lower (60.4 vs 61.2 yrs), and time to treatment
was shorter (2.9 vs 3.1 hrs). Outcomes were:
Prior PTCA No Prior PTCA P-value
24 hr mortality (%) 1.8 2.7 003
30 day mortality (%j 56 70 004
CHF(%) 14.3 163 002
Re-infarction (%) 4.6 4.0 NS
Ischemia (%) 24.0 19.8 <00001
CABG(°/o} 12.2 85 <000001
PTCA(%) 56.2 321 <000001
Conclusion: Patients with prior PTCA had a lower 24-hr and 30-day mortal-
ity and less CHF compared with patients without prior PTCA. Although they
experienced more recurrent ischemia, no increase in re-infarction was ob-
served. The protective effect of prior PTCA may be due to reactive changes in
the treated coronary segment and is associated with a more frequent revas-
cularization.
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1725-61 Persistent Intramyocardial Segmental Dysfunction
After Anterior Infarction Treated with Reperfusion
and ACE Inhibition
Christopher M. Kramer, Walter J. Rogers, Therese M. Theobald,
Orlando Simonetti, Nathaniel Reichek. Medical College ofPennsylvania, Allegheny
Geneval Hospital, Pittsburgh, PA
We have previously demonstrated intra myocardial segmental dysfunction
throughout the LV in the first week after anterior myocardial infarction We
used magnetic resonance tagging (MRI) to determine the evolution in re-
gional intramyocardial function and LV mass index ILVMI), end-diastolic and
end-systolic volumes (EDV, ESV), and ejection fraction (EF) during the first
8 weeks after anterior MI in patients treated with reperfusion and ACE in-
hibitors (ACEI). We studied 10 normals (7 male, 3 female, ages 43 ± 14) and
8 patients (7 male, age 52 ± 16) after first anterior MI with peak CK 2871 ±
2244 with MRI at day 6 ± 2 (week 1) and day 58 ± 10 (week 8) post-MI. All pa-
tients had isolated LAD disease and were reperfused with tPA (n = 1), PTCA
(n = 3), or both (n = 4). All were treated with ACEI and 5 with fJ-blockers at
both time points. Breath-hold, segmented k-space, TurboFlash, tagged im-
ages with the subject prone on an elliptical spine coil were obtained through-
out systole with 7 mm thick short axis slices (n = 11 ± 2) spanning the LV
from apex to base. Global parameters did not change over the 8 week period
(mean ± S.D.):
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Expression of Inducible Nitric Oxide Synthase in the
Myocardium of Acute Myocarditis - A Serial Cardiac
Biopsy Study
Michiaki Hiree, Shigeru Ishiyama, Toshio Nishikawa, Takashi Shimojo, Hiroshi Ito,
Takeshi KasaJima, Fumiaki Marumo. Tokyo Medical and Dental University, Tokyo
Women's Medical College, Tokyo, Japan
In endotoxin shock, hypotension and impaired myocardial contractility may
be caused by increased nitric oxide (NO) formed by inducible NO synthase
(iN OS) which is induced by cytokines and bacteriallipopolysaccarides.
We have investigated whether iNOS is expressed in serially biopsied sam-
ples from the right ventricle of 20 cases of acute myocarditis by immuno-
histochemistry and in situ hybridization. Distinct iNOS immunoreactivity was
observed in cardiomyocytes, endothelial cells, vascular smooth muscle cells
and macrephages in all cases during acute active stage, in which cardiac
function was severely impaired. Immunoelectron microscopic distribution of
iNOS was evident in the cytosol of these cells. However, little staining was
disclosed in the myocardium during the convalescent stage, showing nor-
mal cardiac function. The distribution of myocytes with elevated iNOS mRNA
concentration was identical to that of these immunoreactive cells. Conclu-
sions. The present study shows the expression of human myocardial iNOS in
acute myocarditis, suggesting that the enhanced production of NO by iNOS
is cytotoxic and accounts, in part, for myocardial injury and reduced myocar-
dial contractility during acute illness.
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1726-21 The Role of Myocardial Catecholamine: Promising or
Proved in Diagnosis and Prognosis of Primary Heart
Muscle Diseases?
Petar M. Seferovic, Stepan Stepanovic, Ru~ica Maksimovic, Miodrag Ostojic,
Slavko Simeunovic, Jovan D. Vasillevic, Dragana Seferovic, Arsen Ristic, Dragan
V Simic, Vesna Dangubic. Institute for Cardiovascular Diseases of the University
Medical Center, Belgrade, Yugoslavia
The role of myocardial catecholamine concentration (MCC) in diagnosis and
outcome of primary heart muscle diseases (HMD) is still incompletely de-
fined. To elucidate this problem we analyzed diagnostic utility of MCC mea-
surements in pts with biopsy proven myocarditis (BPM), hypertrophic car-
diomyopathy (HCM). and idiopathic dilated cardiomyopathy (DCM). as well
as MCC prognostic impact in DCM. Our study group consisted of 86 pts, 20
of them with BPM (80% males, aged 18-42 yrs), 34 HCM pts (64% males,
aged 29-54 yrsl and 32 pts with DCM (75% males, aged 21-56 yrs). At the ini-
tial assessment all pts underwent cardiac catheterization and endomyocar-
dial biopsy (EMB). Myocardial norepinephrine (MNEC). epinephrine (MEC).
and dopamine (MDC) concentrations were measured in EMB samples us-
ing catechol-O-methyl-transferase radioenzymatic method. Obtained values
(ng/g of fresh myocardial tissue ft) are shown in the table below:
MNEC MEC MDC
Percent intramyocardial circumferential end-systolic segment shortening
(%S) was measured at 3 transmural locations in each of the 4 regions on each
LV short axis slice. Mean %S ± SO was compared by long axis location:
*p < 0.02 vs. normals, # p < 0.02 vs. 1 week, 'p = 0.07 vs. normals
Significant improvement is limited to the apex, which includes infarcted
and adjacent non infarcted myocardium. In conclusion, while reperfusion and
ACE inhibition blunt remodeling after anterior infarction, intramyocardial seg-
mental function remains depressed throughout the left ventricle.
Week 1 Week 8 p
LVMI (g/m 2 ) 114 ± 22 118 ± 9 NS
EDV(ml) 87 ± 27 108 ± 24 NS
ESV(ml) 55 ± 18 64 ± 29 NS
EF(%) 36 ± 11 42 ± 16 NS
Apex (%)
Mid-ventricle (%)
Base (%)
Normals
23.0 ± 2.9
20.5 ± 2.6
17.0 ± 4.9
Pts. (Week 1)
6.3 ± 6.3*
8.6 ± 4.4*
11.3 ± 3.7*
Pts. (Week 8)
10.0 ± 3*#
11.3 ± 4.3*
13.5 ± 3.2'
BPM 415.4±71.1 t 57.3±48' 766±9.2ns
HCM 781.0± 125.1** 91.3± 13.1** 78.1 ±9.3ns
DCM 262.2 ± 68.9' 36.9 ± 7.1' 726 ± 12.1 ns
top < 001 (BPM vs. DCM); **-p < 001 (HCM vs. BPM); top < 0.01 (HCM vS. DCM)
In addition, we analyzed the effect of MNEC and MEC on the five years sur-
vival of 31 DCM pts. Survival 118131 )was significantly better in pts With higher
MNEC (411.8 ± 43.4 nglg ft survivors vs. 278.5 ± 75.7 nglg ft non-survivors,
p < 0.01) and MEC (55.3 ± 4.5 nglg ft survivors vs. 39.2 ± 9.3 nglg ft non-
survivors, p < 0.01). Univariate and multivariate analysis demonstrated that
both MNEC and MEC predicted long-term survival independently and their
low concentrations were associated with increased mortality.
In conclusion, these data indicate that MCC measurements may be helpful
as a complementary tool in diagnostic evaluation of pts with HMO. Further-
more, MNEC and MECshould be considered as valuable prognostic markers
of the long-term survival of DCM pts.
